LifeMD (LFMD) Shares Outstanding (Weighted Average) (2016 - 2026)
LifeMD filings provide 14 years of Shares Outstanding (Weighted Average) readings, the most recent being $45.1 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 9.55% to $45.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.1 million, a 9.55% increase, with the full-year FY2025 number at $45.1 million, up 9.55% from a year prior.
- Shares Outstanding (Weighted Average) hit $45.1 million in Q4 2025 for LifeMD, down from $46.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.2 million in Q3 2025 to a low of $24.5 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $33.2 million (2023), compared with a mean of $35.0 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): surged 128.72% in 2021 and later rose 2.68% in 2023.
- LifeMD's Shares Outstanding (Weighted Average) stood at $27.0 million in 2021, then increased by 14.69% to $31.0 million in 2022, then rose by 9.45% to $33.9 million in 2023, then grew by 21.5% to $41.2 million in 2024, then rose by 9.55% to $45.1 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $45.1 million (Q4 2025), $46.2 million (Q3 2025), and $43.8 million (Q2 2025) per Business Quant data.